The study identified five predictors of overall survival (OS) post-transplant in HBV-related HCC patients: variables beyond the Milan criteria, pre-transplant AFP (alpha-fetoprotein) levels exceeding 400, poor tumor differentiation, microvascular invasion, and HBV reactivation. The gene discussed is AFP; the disease is hepatocellular carcinoma.